Navigation Links
Steroids May Be Overrated in Treatment of COPD
Date:2/4/2010

But experts disagree over whether to continue using them or not,,

THURSDAY, Feb. 4 (HealthDay News) -- Patients suffering from chronic obstructive pulmonary disease (COPD) are often given inhaled corticosteroids to help ease exacerbations of the disease, but a new study finds these drugs may be of only limited benefit.

While inhaled corticosteroids have been widely prescribed to help treat the symptoms of COPD, they have also been linked to an increased risk of pneumonia, the researchers note.

"I think the study is important and shows that the benefits of addition of inhaled corticosteroids to long-acting beta agonist formulations are only minimal compared to significant risks of pneumonia," said Dr. Sonal Singh, an assistant professor of medicine at Johns Hopkins University, who was not involved in the study.

"Unfortunately, therapeutic options for patients with COPD are limited and carry their own risks such as cardiovascular risks with anticholinergics," he added. "Thus a regulatory reassessment of the safety of COPD inhalers is needed."

COPD is an incurable condition that progressively destroys the lungs. While there is no cure, various medications can help treat the symptoms, including inhaled corticosteroids, long-acting beta agonists such as Serevent, short-acting beta agonists such as albuterol, and anticholinergics such as Spiriva.

Singh noted that while inhaled corticosteroids don't seem to add much to the treatment of COPD, long-acting beta agonists are not approved for use without them. "It's a real catch-22. It's not clear that there are any benefits and we know that the harms are substantial," Singh said.

"I sometimes use inhaled corticosteroids, but it's becoming less and less," he added.

The report is published in the February issue of the journal Chest.

For the study, Dr. Ritesh Agarwal and colleagues from the department of pulmonary medicine at the Postgraduate Institute of Medical Education and Research in Chandigarh, India, looked at 11 studies that compared inhaled corticosteroids with placebos in some 8,164 COPD patients.

The researchers found that these drugs only had a modest effect in reducing the number of exacerbations. In fact, even this small benefit was limited to patients who had lost more than 50 percent of their lung function.

Yet, further analysis of the data found that even 50 percent of lung function was not a predictor of the ability of inhaled corticosteroids to reduce the number of exacerbations, Agarwal's team found.

Given these findings, the researchers say that "the role of inhaled corticosteroids in preventing COPD exacerbations needs reappraisal."

However, Dr. Neil Schachter, a professor of pulmonary medicine at Mount Sinai Medical Center in New York City, isn't ready to give up on inhaled corticosteroids.

"There does appear to be an improvement in terms of the rate of exacerbations of patients with COPD who take drugs that contain corticosteroids," he said. "That confirms what most people believe, that if you treat COPD with most of the drugs we use to treat it, you can reduce and delay the onset of exacerbations."

Schachter treats most of his COPD patients with a combination of drugs. Many patients take inhaled corticosteroids, long-acting beta agonists and the anticholinergic Spiriva. He said the effects of these drugs are additive, making for a more powerful treatment than using a single drug.

"My bias is to use everything," he said. "My impression is that these patients do better on triple therapy. They have better lives, less symptoms, fewer exacerbations and they probably live a bit longer."

Another report in the same issue of the journal found that COPD patients have a high rate of depression. In this study, a research team led by Christoph R. Meier, from University Basel in Switzerland, collected data on 35,722 COPD patients and 35,722 healthy people.

The researchers found among those with COPD, 23.1 percent were diagnosed with depression, compared with 16.8 percent of people without COPD. Moreover, those with the most severe COPD had the greatest risk of developing depression.

More information

For more information on COPD, visit the U.S. National Heart, Lung, and Blood Institute.



SOURCES: Sonal Singh, M.D., M.P.H., assistant professor, medicine, Johns Hopkins University, Baltimore; Neil Schachter, M.D., professor, pulmonary medicine, Mount Sinai Medical Center, New York City; February 2010, Chest


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Steroids Seem Safe for Babies at Risk of Early Birth
2. Batters may achieve dramatic increases in home runs through steroids
3. Repeat steroids to premature infants linked to cerebral palsy
4. International Law Enforcement Operation Targets Underground Manufacture of Anabolic Steroids
5. Steroids Are Abused for Skin, Not Just Muscles
6. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
7. ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more
8. Corticosteroids of Little Use Against Childhood Meningitis
9. Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids
10. Changes in sex steroids associated with menopause
11. Steroids aid recovery from pneumonia, UT Southwestern researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Robert E. Burke, MD, PhD, had a ... impoverished upbringing and life experiences could have led him down a much different path. ... Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares a personal account of the ...
(Date:2/27/2017)... ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She ... to become a nun. Now, she writes about God, when she isn’t swimming as a ... and AD, Here is BS! (Before Satan),” she offers a comedic look at the dysfunctions ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from ... scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society ... B. Liegner, M.D. has compiled into a single volume a compelling argument that the ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... to announce an upgrade to the company's Yelp listing. Bay Area residents struggling ... as diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... 2011 the lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited ... allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets out ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... The Netherlands , Feb 27, 2017 ... is approved by NATO for use at the security ... security imposed within the NATO organization for the communication of ... ... providing government authorities with an eavesdrop-secure smartphone solution. Sectra Tiger/R ...
(Date:2/24/2017)... February 24, 2017 Following receiving ... Israel , s AMAR is a major ... 250 M w ound care market in ... BST for inclusion in the National Health Basket ...   E-QURE Corp. (OTCQB: EQUR), a leader ...
(Date:2/24/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the Cowen and Company 37 th ... Place on Tuesday, March 7, 2017 at 11:20 a.m. ... the presentation can be accessed at http://wsw.com/webcast/cowen38/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Medicine Technology: